Radiopharm Theranostics (RADX) has executed a subscription agreement for a private placement of ordinary shares to Lantheus Holdings (LNTH), raising $5M. The placement of 133 million shares was completed at an issue price of A$0.060 per share, representing a 150% premium to the last traded price of RAD shares. Settlement is expected to occur within 7 days. The placement replaces 6-month options that the Company issued in August 2024.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LNTH: